NEWM&A

Kyntra Bio Inc (KYN) Form 4 Filed on June 17

Published on 6/17/2026

#KYN#insiderTrading#SEC#Form4
Kyntra Bio Inc (KYN) Form 4 Filed on June 17

AI Summary

On June 17, Kyntra Bio Inc (KYN) filed Form 4 with the SEC, reflecting insider trading activity. The form disclosed stock transactions and potential changes in beneficial ownership among executive officers. These filings are significant as they provide transparency on insider actions which can influence investor perceptions. The specific details of the stock transactions made on this date were not included in the article.

Source: Read original article (opens in new tab)

Related News

Oncotelic (OTLC) Reports Form 4 Filing; Date: June 17
Markets

Oncotelic (OTLC) Reports Form 4 Filing; Date: June 17

Jun 17

ImageneBio (IMGN) Stockholders Approve Equity Plan Amendment
M&A

ImageneBio (IMGN) Stockholders Approve Equity Plan Amendment

Jun 17

Form 4 ACNB Corporation (ACNB) Filed on June 17
Regulation

Form 4 ACNB Corporation (ACNB) Filed on June 17

Jun 17

Farmers National Banc Corp (FMNB) Form 144 Filed on June 17
Regulation

Farmers National Banc Corp (FMNB) Form 144 Filed on June 17

Jun 17